text.skipToContent text.skipToNavigation

Cost-Effectiveness Analysis in Health A Practical Approach von Muennig, Peter (eBook)

  • Erscheinungsdatum: 03.02.2016
  • Verlag: Jossey-Bass
eBook (ePUB)

77,99 €1

73,99 €
inkl. gesetzl. MwSt.
Sofort per Download lieferbar

Online verfügbar

Cost-Effectiveness Analysis in Health

The field's bestselling reference, updated with the latest tools, data, and techniques Cost-Effectiveness Analysis in Health is a practical introduction to the tools, methods, and procedures used worldwide to perform cost-effective research. Covering every aspect of a complete cost-effectiveness analysis, this book shows you how to find which data you need, where to find it, how to analyze it, and how to prepare a high-quality report for publication. Designed for the classroom or the individual learner, the material is presented in simple and accessible language for those who lack a biostatistics or epidemiology background, and each chapter includes real-world examples and 'tips and tricks' that highlight key information. Exercises throughout allow you to test your understanding with practical application, and the companion website features downloadable data sets for students, as well as lecture slides and a test bank for instructors. This new third edition contains new discussion on meta-analysis and advanced modeling techniques, a long worked example using visual modeling software TreeAge Pro, and updated recommendations from the U.S. Public Health Service's Panel on Cost-Effectiveness in Health and Medicine. Cost-effectiveness analysis is used to evaluate medical interventions worldwide, in both developed and developing countries. This book provides process-specific instruction in a concise, structured format to give you a robust working knowledge of common methods and techniques. Develop a thoroughly fleshed-out research project Work accurately with costs, probabilities, and models Calculate life expectancy and quality-adjusted life years Prepare your study and your data for publication
Comprehensive analysis skills are essential for students seeking careers in public health, medicine, biomedical research, health economics, health policy, and more. Cost-Effectiveness Analysis in Health walks you through the process from a real-world perspective to help you build a skillset that's immediately applicable in the field.


    Format: ePUB
    Kopierschutz: AdobeDRM
    Seitenzahl: 480
    Erscheinungsdatum: 03.02.2016
    Sprache: Englisch
    ISBN: 9781119011286
    Verlag: Jossey-Bass
    Größe: 12209 kBytes
Weiterlesen weniger lesen

Cost-Effectiveness Analysis in Health



1.1 Hypothetical League Table for a Village in Malawi with a $58,000 Health Budget
2.1 Costs Included in a Cost-Effectiveness Analysis of Free Contraception, Conducted from Three Perspectives
2.2 Hypothetical Differences in Health-Related Quality of Life over 10 Years for Diabetic Women and Women in Perfect Health
2.3 Decision Matrix for Various Cost-Effectiveness Scenarios
4.1 Comparison of Pharmaceutical Benchmark Prices
4.2 Partial List of Costs for Treatment of Influenza Infection
4.3 Common Codes Used to Group Diseases
4.4 MEDPAR Cost Data by DRG for 2011
4.5 Medical Component of the Consumer Price Index 2004-2014, Annual Percentage Change over Previous Year
4.6 Hypothetical and Discounted Costs of a Cohort of 1,000 Elderly Persons over 10 Years
5.1 Probabilities and Costs for Vaccinated and Not Vaccinated (Supportive Care) Strategies
5.2 Calculation of Expected Cost for Each Event Pathway for Vaccination and Supportive Care Strategies
6.1 Number of Deaths due to Influenza Virus Infection, by Age Group
6.2 Deaths, Mean Age of Death due to Influenza Virus Infection, and Life Expectancy for Persons Aged 15 to 65
6.3 Calculating Total Years of Life Lost due to Influenza Virus Infection in the United States
6.4 Total Deaths, Deaths due to Influenza Virus Infection, and Total Survivors in a Cohort of 1 Million 15-Year-Olds
6.5 Total Person-Years Lived by the Cohort of 1 Million 15-Year-Olds
6.6 Person-Years Lived Among the Cohort of 15-Year-Olds, Including and Excluding Deaths due to Influenza Virus Infection
6.7 Age-Specific Mortality Rates, Survivors, and Number of Deaths in the Cohort of 1 Million 15-Year-Old Subjects
6.8 Progression of a Cohort of 10 Women with Breast Cancer over a Six-Year Period
7.1 Example of How an HRQL Score for Influenza Illness May Be Derived Using the EQ-5D
7.2 EQ-5D Preference Score Variation Among Age Categories
8.1 Total Person-Years Lived by the Cohort of 1 Million 15-Year-Olds
8.2 Sum of Person-Years Across Age Groups for the Cohort of 1 Million 15-Year-Olds
8.3 Calculating Life Expectancy at a Given Age
8.4 Abridged Life Table for 2011
8.5 A Quality-Adjusted Life Table
10.1 Simple Summary of Costs Used in a Cost-Effectiveness Model
10.2 Cost-Effectiveness Table
10.3 Example of a Cost-Effectiveness Table
11.1 Calculating the Incidence Rate of Developing Cancer due to Exposure to Radiation in a Two-Year Observation Period, 2011-2012
11.2 Calculating the Age-Adjusted Mortality Rate Using a Hypothetical U.S. Population
11.3 Frequency Distribution of Hypothetical Cholesterol Values Obtained from 100 Subjects
12.1 Datasets Useful for Finding Frequently Needed Cost-Effectiveness Parameters
13.1 Results of the Base-Case Analysis
13.2 Age-Indexed Table for Use in the New Tree
13.3 Base-Case Results for the Markov Model
13.4 Base-Case Results After Applying a 3 Percent Discount Rate
13.5 Results After Terminating Calculations at Age 65 or Older
A.1 Comparison Between Vaccinated and Not Vaccinated Strategies
A.2 Markov Model Using a Vaccine Effectiveness of 75 Percent
B.1 Abridged Life Table for the Total Population, United States, 2011
B.2 Abridged Quality-Adjusted Life Table for the Total Population, United States, 2011 Fig

Weiterlesen weniger lesen